These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1501896)

  • 41. Postirradiation induration as a prognosticator. A retrospective analysis of squamous-cell carcinomas of the oral cavity and oropharynx.
    Fazekas JT; Green JP; Vaeth JM; Schroeder AF
    Radiology; 1972 Feb; 102(2):409-12. PubMed ID: 5009950
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of patients with clinically lymph node-negative squamous cell carcinoma of the oral cavity.
    Jang WI; Wu HG; Park CI; Kim KH; Sung MW; Kim MJ; Choung PH; Lee JH; Choi JY
    Jpn J Clin Oncol; 2008 Jun; 38(6):395-401. PubMed ID: 18573849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute reaction and late damage of the normal tissue in cancer patients given a dynamic dose-fractionation under breathing of oxygen.
    Siracká E; Durkovský J; Jancina J; Révész L
    Neoplasma; 1973; 20(6):643-53. PubMed ID: 4773312
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical and technical aspects of radiation therapy of oropharyngeal cancer (author's transl)].
    Ghilezan N; Milea N; Moguţ D; Tamburlini S
    Radiobiol Radiother (Berl); 1978; 19(1):45-53. PubMed ID: 663079
    [No Abstract]   [Full Text] [Related]  

  • 45. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
    Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
    Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
    Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
    Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The presentation of malignant lymphoma in the oral cavity and pharynx.
    Lehrer S; Roswit B; Federman Q
    Oral Surg Oral Med Oral Pathol; 1976 Apr; 41(4):441-50. PubMed ID: 817243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Radiation and chemoradiation therapy of malignant laryngopharyngeal tumors].
    Morozov AI; Rogachikova TA; Korshunov AI; Biriukov VA; Pinskaia LG
    Med Radiol (Mosk); 1985 Aug; 30(8):15-8. PubMed ID: 4033383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical pathology of cancer of the oral cavity and oropharynx.
    Brennan CT; Sessions DG; Spitznagel EL; Harvey JE
    Laryngoscope; 1991 Nov; 101(11):1175-97. PubMed ID: 1943419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers.
    Lin CY; Wang HM; Kang CJ; Lee LY; Huang SF; Fan KH; Chen EY; Chen IH; Liao CT; Chang JT
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1011-9. PubMed ID: 20434273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
    Kang CJ; Lin CY; Wang HM; Fan KH; Ng SH; Lee LY; Chen IH; Huang SF; Liao CT; Yen TC
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e223-30. PubMed ID: 21640500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinicopathological study of advanced cancers of the oral cavity and pharynx--evaluation of the effects of chemotherapy and radiotherapy].
    Koieke S; Uno K; Ogawa T; Mandai K; Doihara H; Moriwaki S
    Gan No Rinsho; 1989 Jun; 35(7):834-9. PubMed ID: 2472497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Major complications of radiotherapy in cancer of the oral cavity and oropharynx. A 10 year retrospective study.
    Larson DL; Lindberg RD; Lane E; Goepfert H
    Am J Surg; 1983 Oct; 146(4):531-6. PubMed ID: 6625100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Program of the combined treatment of Hodgkin's disease. I. Evaluation of the early results of radical radiotherapy by the mantle field technic in patients with Hodgkin's disease in clinical stages I-III].
    Meder J; Fijuth J
    Nowotwory; 1985; 35(3):262-71. PubMed ID: 4088902
    [No Abstract]   [Full Text] [Related]  

  • 55. Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity.
    Hoeller U; Biertz I; Flinzberg S; Tribius S; Schmelzle R; Alberti W
    Strahlenther Onkol; 2006 Mar; 182(3):157-63. PubMed ID: 16520910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx.
    Richard JM; Sancho H; Lepintre Y; Rodary J; Pierquin B
    Cancer; 1974 Sep; 34(3):491-6. PubMed ID: 4852531
    [No Abstract]   [Full Text] [Related]  

  • 57. Radiation therapy of ovarian carcinoma: presentation of a six-field technique.
    Einhorn N; von Hamos K; Hindmarsh T; Lagergren C; Lundell M; Mellstedt H; Tjernberg B
    Radiother Oncol; 1986 Oct; 7(2):125-31. PubMed ID: 3097763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mantle treatment. Absorbed dose measurements in patients compared with dose planning.
    Svahn-Tapper G
    Acta Radiol Ther Phys Biol; 1976 Aug; 15(4):340-56. PubMed ID: 983784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Non-Hodgkin pharyngeal lymphoma from case records of the Cracow Cancer Institute].
    Reinfuss M; Skołyszewski J
    Nowotwory; 1981; 31(1):55-61. PubMed ID: 7290997
    [No Abstract]   [Full Text] [Related]  

  • 60. Malignant tumours of the oropharynx.
    Andersen AP; Bertelsen K; Elbrond O; Gadeberg C; Lund C
    Acta Radiol Ther Phys Biol; 1977 May; 16(1):63-72. PubMed ID: 868574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.